Aberdeen Group plc

Holdings History for Fulcrum Therapeutics, Inc. - Common Stock, $0.001 par value per share (FULC)

Symbol: FULC on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.02%	+0.02%	$14,183,045	1,254,027	+1,116,066	+809%	$11.31	Q4 2025
30 Sep 2025	0%	+0%	$1,269,241	137,961	+79,265	+135%	$9.20	Q3 2025
30 Jun 2025	0%	+0%	$403,828	58,696	+58,696	NEW	$6.88	Q2 2025
30 Sep 2024		-0%	$0	0	-256,888	-100%	$10.94	Q3 2024
30 Jun 2024	0%	0%	$1,592,706	256,888	0		$6.20	Q2 2024
31 Mar 2024	0%	0%	$2,425,023	256,888	0		$9.44	Q1 2024
31 Dec 2023	0%	+0%	$1,733,994	256,888	+256,888	NEW	$6.75	Q4 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.